Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Aide

Showing results (41-50 of 119) with videos related to

Pageof 12
Sort By:
The Journal of Clinical Endocrinology and Metabolism|June 23, 2012
Unusual short-term complete response to two regimens of cytotoxic chemotherapy in a patient with poorly differentiated thyroid carcinomaGeneviève Crouzeix, Jean-Jacques Michels, Emmanuel Sevin, et al.
Frontiers in Oncology|January 29, 2021
Hormonal Receptor Immunochemistry Heterogeneity and <sup>18</sup>F-FDG Metabolic Heterogeneity: Preliminary Results of Their Relationship and Prognostic Value in Luminal Non-Metastatic Breast CancersNicolas Aide, Nicolas Elie, Cécile Blanc-Fournier, et al.
Molecular Imaging and Biology|April 1, 2009
Early 2'-deoxy-2'-[18F]fluoro-D-glucose PET metabolic response after corticosteroid therapy to differentiate cancer from sarcoidosis and sarcoid-like lesionsNicolas Aide, Djelila Allouache, Yann Ollivier, et al.
EJNMMI Research|December 5, 2018
Optimization of a dedicated protocol using a small-voxel PSF reconstruction for head-and-neck <sup>18</sup>FDG PET/CT imaging in differentiated thyroid cancerRenaud Ciappuccini, Cédric Desmonts, Idlir Licaj, et al.
EJNMMI Research|January 19, 2013
Contrast-enhanced small-animal PET/CT in cancer research: strong improvement of diagnostic accuracy without significant alteration of quantitative accuracy and NEMA NU 4-2008 image quality parametersCharline Lasnon, Elske Quak, Mélanie Briand, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 5, 2022
PET/CT variants and pitfalls in malignant melanomaNicolas Aide, Amir Iravani, Kevin Prigent, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 8, 2004
[18F]FDG in recurrent breast cancer: diagnostic performances, clinical impact and relevance of induced changes in managementDany Grahek, Françoise Montravers, Khaldoun Kerrou, et al.
European Journal of Radiology|June 28, 2020
How fast can we scan patients with modern (digital) PET/CT systems?Charline Lasnon, Nicolas Coudrais, Benjamin Houdu, et al.
Scientific Reports|December 11, 2021
Diagnostic value of baseline <sup>18</sup>FDG PET/CT skeletal textural features in follicular lymphomaJulie Faudemer, Nicolas Aide, Anne-Claire Gac, et al.
Annals of Nuclear Medicine|November 5, 2016
Generating harmonized SUV within the EANM EARL accreditation program: software approach versus EARL-compliant reconstructionCharline Lasnon, Thibault Salomon, Cédric Desmonts, et al.
Pageof 12

Showing results (41-50 of 119) with videos related to

Sort By:
Pageof 12
The Journal of Clinical Endocrinology and Metabolism|June 23, 2012
Unusual short-term complete response to two regimens of cytotoxic chemotherapy in a patient with poorly differentiated thyroid carcinomaGeneviève Crouzeix, Jean-Jacques Michels, Emmanuel Sevin, et al.
Frontiers in Oncology|January 29, 2021
Hormonal Receptor Immunochemistry Heterogeneity and <sup>18</sup>F-FDG Metabolic Heterogeneity: Preliminary Results of Their Relationship and Prognostic Value in Luminal Non-Metastatic Breast CancersNicolas Aide, Nicolas Elie, Cécile Blanc-Fournier, et al.
Molecular Imaging and Biology|April 1, 2009
Early 2'-deoxy-2'-[18F]fluoro-D-glucose PET metabolic response after corticosteroid therapy to differentiate cancer from sarcoidosis and sarcoid-like lesionsNicolas Aide, Djelila Allouache, Yann Ollivier, et al.
EJNMMI Research|December 5, 2018
Optimization of a dedicated protocol using a small-voxel PSF reconstruction for head-and-neck <sup>18</sup>FDG PET/CT imaging in differentiated thyroid cancerRenaud Ciappuccini, Cédric Desmonts, Idlir Licaj, et al.
EJNMMI Research|January 19, 2013
Contrast-enhanced small-animal PET/CT in cancer research: strong improvement of diagnostic accuracy without significant alteration of quantitative accuracy and NEMA NU 4-2008 image quality parametersCharline Lasnon, Elske Quak, Mélanie Briand, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 5, 2022
PET/CT variants and pitfalls in malignant melanomaNicolas Aide, Amir Iravani, Kevin Prigent, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 8, 2004
[18F]FDG in recurrent breast cancer: diagnostic performances, clinical impact and relevance of induced changes in managementDany Grahek, Françoise Montravers, Khaldoun Kerrou, et al.
European Journal of Radiology|June 28, 2020
How fast can we scan patients with modern (digital) PET/CT systems?Charline Lasnon, Nicolas Coudrais, Benjamin Houdu, et al.
Scientific Reports|December 11, 2021
Diagnostic value of baseline <sup>18</sup>FDG PET/CT skeletal textural features in follicular lymphomaJulie Faudemer, Nicolas Aide, Anne-Claire Gac, et al.
Annals of Nuclear Medicine|November 5, 2016
Generating harmonized SUV within the EANM EARL accreditation program: software approach versus EARL-compliant reconstructionCharline Lasnon, Thibault Salomon, Cédric Desmonts, et al.
Pageof 12